SiMPore, Inc.
WEST HENRIETTA, NY · Founded 2007 · CIK 0001431967 · Biotech · Private
Freely suspended silicon nanomembrane technology for biomedical and material science applications
simpore.com →- Grants
- $8.1M
- 17 awards
- Sector median: 1
- Raised
- $1.0M
- 1 Form D · Jun 2010
- 196 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 24
- 6 granted · 18 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20092011201320152017201920212023
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $1,000,000 | |
| Federal grant | National Science Foundation · Phase I · STTR Phase I: Development of Ultrathin Nanomembranes for Home-based Hemodialysis | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Enabling Nanomembrane-Based Biomolecule and Nanoparticle Separations | $198,938 | |
| Federal grant | Department of Health and Human Services · Phase I · Enabling Nanomembrane-Based Biomolecule and Nanoparticle Separations | $198,938 | |
| Federal grant | National Science Foundation · Phase II · STTR Phase II: Development of Ultrathin Nanomembranes for Home-based Hemodialysis | $907,724 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Microfabrication-based Biomimetic Approach for In Vitro Red Blood Cell Maturation | $225,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Microfabrication based Biomimetic Approach for In Vitro Red Blood Cell Maturation | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Isoporous Silicon Nanomembranes for Purification of Therapeutic Viruses | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Isoporous Silicon Nanomembranes for Purification of Therapeutic Viruses | $225,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · SEA-PUR: A New Platform for Improved Microplastic Contamination Surveillance | $225,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · SEA-PUR: A New Platform for Improved Microplastic Contamination Surveillance | $225,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Commercializing the µSIM: A Modular Platform for the Development and Analysis of Barrier Tissue Models | $235,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Commercializing the µSIM:A Modular Platform for the Development and Analysis of Barrier Tissue Models | $235,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercialization of Novel Silicon Microslit Filters for Microplastic Contamination Testing | $667,570 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercializing the μSIM: A Modular Platform for the Development and Analysis of Barrier Tissue Models | $893,657 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercializing the μSIM: A Modular Platform for the Development and Analysis of Barrier Tissue Models | $1,694,475 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercialization of Novel Silicon Microslit Filters for Microplastic Contamination Testing | $703,511 | |
| Federal grant | Department of Health and Human Services · Phase II · Commercializing the μSIM: A Modular Platform for the Development and Analysis of Barrier Tissue Models | $800,818 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3337 | PURE BIOSCIENCE, INC. | — | $29M |
| 3338 | Timberlyne Therapeutics | — | — |
| 3339 | POP Biotechnologies Inc. | — | — |
| 3340 | SiMPore, Inc. | — | $1.0M |
| 3341 | DATIRIUM LLC | — | — |
| 3342 | Stealth Biosciences, Inc | — | — |
| 3343 | SOMATOLYNK, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Mark AinDirector
- Phillippe FauchetDirector
- Ted FranceschiDirector
- Thomas GaborskiDirector · Executive Officer
- James McGrathDirector · Promoter
- Kevin ParkerDirector
- Richard RichmondDirector · Executive Officer · Promoter
- Geoff RosenbergerDirector
- Christopher StriemerExecutive Officer
Patents
- Extracellular Vesicle Isolation By Nanomembranesgranted
- Extracellular Vesicle Isolation by Nanomembranesgranted
- Devices, Methods, And Kits For Sample Analysis Using Microslit Filtersapplication
- Functionalized Silicon Nanomembranes And Uses Thereofapplication
- Methods For Creating Fluidic Cavities By Transmembrane Etching Through Porous Membranes And Structures Made Thereby And Uses Of Such Structuresgranted
- Nanoporous Silicon Nitride Membranes, And Methods For Making And Using Such Membranesgranted
- Free-standing Silicon Oxide Membranes And Methods Of Making And Using Samegranted
- Nanoporous Silicon Nitride Membranes, And Methods For Making And Using Such Membranesgranted
- High-performance, Low-voltage Electroosmotic Pumps With Molecularly Thin Nanomembranesapplication
- Methods For Creating Fluidic Cavities By Transmembrane Etching Through Porous Membranes And Structures Made Thereby And Uses Of Such Structuresapplication
- Free-standing Silicon Oxide Membranes And Methods Of Making And Using Sameapplication
- Nanoporous Silicon Nitride Membranes, And Methods For Making And Using Such Membranesapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.